Loading clinical trials...
Loading clinical trials...
This pilot study will explore the relationship of Ochratoxin A (OTA) levels in patients with upper tract transitional cell (TCC), renal cell, and testicular cancers by measuring levels of OTA in serum...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
NCT06500455 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more
NCT07540260 · Radiation Therapy, Metastatic Renal Cancer, and more
NCT07218913 · Hearing Loss, Metastatic Malignant Germ Cell Tumor, and more
St. Josephs Health Care
London, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions